Skip to main content
Premium Trial:

Request an Annual Quote

TTP Licenses Sample-to-Answer Dx System to DiaSorin

NEW YORK — British technology and product development company TTP has exclusively licensed its Puckdx sample-to-answer molecular diagnostics system to DiaSorin for human in vitro diagnostic (IVD) applications, the companies said on Monday.

Puckdx is a disposable robotic pipette system with a PCR module that runs reagent-containing test cartridges. According to the companies, Saluggia, Italy-based DiaSorin will use the system as the basis of a point-of-care diagnostic platform for single-use assays.

Additional terms of the deal were not disclosed. TTP noted that DiaSorin's license does not include areas outside of human IVDs such as sample preparation and animal health.

"We are delighted that DiaSorin has chosen Puckdx as their preferred POC platform," TTP Consultant Giles Sanders said in a statement. "We look forward to working in close partnership with DiaSorin to rapidly commercialize the platform."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.